{"nct_id":"NCT02563002","title":"Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2015-11-30","start_date_type":"ACTUAL","primary_completion_date":"2021-02-19","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}